Teva cuts guidance yet again as Copaxone copies, generics pressure take their toll | Fierce Pharma
DEF 14A
Teva Pharmaceutical Stock Dives Despite a Better-Than-Expected Earnings Report | Barron's
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Pharmaceuticals on LinkedIn: #quarterlyresults #earnings #tevapharm
Teva Reports First Quarter 2021 Financial Results | Business Wire
Teva Reports Second Quarter 2020 Financial Results | Business Wire
Teva Reports Earnings Tomorrow. Here's What to Expect. | Barron's
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Limited (TEVA) Market Cap (2012-2022) History
Teva Reports Third Quarter 2021 Financial Results | Business Wire
Teva Pharmaceuticals Overtakes Key Level Post-Earnings
Teva Pharma Q2 Revenues Drop 18% | BioSpace
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Teva Up 25% on NYSE Since Third Quarter Reports | Ctech
Q3 pharma earnings roundup: Moderna, Regeneron and Teva
Why It Is Time To Load Up On Teva Stock (NYSE:TEVA) | Seeking Alpha
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
